1
|
La Vecchia C, Bosetti C, Lucchini F,
Bertuccio P, Negri E, Boyle P and Levi F: Cancer mortality in
Europe, 2000–2004, and an overview of trends since 1975. Ann Oncol.
21:1323–1360. 2010. View Article : Google Scholar : PubMed/NCBI
|
2
|
Byler S, Goldgar S, Heerboth S, Leary M,
Housman G, Moulton K and Sarkar S: Genetic and epigenetic aspects
of breast cancer progression and therapy. Anticancer Res.
34:1071–1077. 2014.PubMed/NCBI
|
3
|
Seidah NG and Chrétien M: Proprotein and
prohormone convertases: A family of subtilases generating diverse
bioactive polypeptides. Brain Res. 848:45–62. 1999. View Article : Google Scholar : PubMed/NCBI
|
4
|
Nagahama M, Taniguchi T, Hashimoto E,
Imamaki A, Mori K, Tsuji A and Matsuda Y: Biosynthetic processing
and quaternary interactions of proprotein convertase SPC4 (PACE4).
FEBS Lett. 434:155–159. 1998. View Article : Google Scholar : PubMed/NCBI
|
5
|
Mains RE, Berard CA, Denault JB, Zhou A,
Johnson RC and Leduc R: PACE4: A subtilisin-like endoprotease with
unique properties. Biochem J. 321:587–593. 1997. View Article : Google Scholar : PubMed/NCBI
|
6
|
Couture F, D'Anjou F, Desjardins R,
Boudreau F and Day R: Role of proprotein convertases in prostate
cancer progression. Neoplasia. 14:1032–1042. 2012. View Article : Google Scholar : PubMed/NCBI
|
7
|
Longuespée R, Couture F, Levesque C,
Kwiatkowska A, Desjardins R, Gagnon S, Vergara D, Maffia M,
Fournier I, Salzet M and Day R: Implications of proprotein
convertases in ovarian cancer cell proliferation and tumor
progression: Insights for PACE4 as a therapeutic target. Transl
Oncol. S1936–S5233. 2014.
|
8
|
Bassi DE, Zhang J, Cenna J, Litwin S,
Cukierman E and Klein-Szanto AJ: Proprotein convertase inhibition
results in decreased skin cell proliferation, tumorigenesis, and
metastasis. Neoplasia. 12:516–526. 2010. View Article : Google Scholar : PubMed/NCBI
|
9
|
Lapierre M, Siegfried G, Scamuffa N,
Bontemps Y, Calvo F, Seidah NG and Khatib AM: Opposing function of
the proprotein convertases furin and PACE4 on breast cancer cells'
malignant phenotypes: Role of tissue inhibitors of
metalloproteinase-1. Cancer Res. 67:9030–9034. 2007. View Article : Google Scholar : PubMed/NCBI
|
10
|
Wang F, Wang L, Jiang H, Chang X and Pan
J: Inhibition of PCSK6 may play a protective role in the
development of rheumatoid arthritis. J Rheumatol. 42:161–169. 2015.
View Article : Google Scholar : PubMed/NCBI
|
11
|
Sansone P and Bromberg J: Targeting the
interleukin-6/Jak/stat pathway in human malignancies. J Clin Oncol.
30:1005–1014. 2012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Akiyama T and Kawasaki Y: Wnt signalling
and the actin cytoskeleton. Oncogene. 25:7538–7544. 2006.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Larue L and Delmas V: The WNT/Beta-catenin
pathway in melanoma. Front Biosci. 11:733–742. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Lai SL, Chien AJ and Moon RT: Wnt/Fz
signaling and the cytoskeleton: Potential roles in tumorigenesis.
Cell Res. 19:532–545. 2009. View Article : Google Scholar : PubMed/NCBI
|
15
|
Teo JL and Kahn M: The Wnt signaling
pathway in cellular proliferation and differentiation: A tale of
two coactivators. Adv Drug Deliv Rev. 62:1149–1155. 2010.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Bromberg JF, Wrzeszczynska MH, Devgan G,
Zhao Y, Pestell RG, Albanese C and Darnell JE Jr: Stat3 as an
oncogene. Cell. 98:295–303. 1999. View Article : Google Scholar : PubMed/NCBI
|
17
|
Bontemps Y, Scamuffa N, Calvo F and Khatib
AM: Potential opportunity in the development of new therapeutic
agents based on endogenous and exogenous inhibitors of the
proprotein convertases. Med Res Rev. 27:631–648. 2007. View Article : Google Scholar : PubMed/NCBI
|
18
|
Basak A: Inhibitors of proprotein
convertases. J Mol Med. 83:844–855. 2005. View Article : Google Scholar : PubMed/NCBI
|
19
|
Wang F, Wang L and Pan J: PACE4 regulates
proliferation, migration and invasion in human breast cancer
MDA-MB-231 cells. Mol Med Rep. 11:698–704. 2015. View Article : Google Scholar : PubMed/NCBI
|
20
|
Fu J, Bassi DE, Zhang J, Li T, Cai KQ,
Testa CL, Nicolas E and Klein-Szanto AJ: Enhanced UV-induced skin
carcinogenesis in transgenic mice overexpressing proprotein
convertases. Neoplasia. 15:169–179. 2013. View Article : Google Scholar : PubMed/NCBI
|
21
|
Li M, Lewis B, Capuco AV, Laucirica R and
Furth PA: WAP-TAg transgenic mice and the study of dysregulated
cell survival, proliferation, and mutation during breast
carcinogenesis. Oncogene. 19:1010–1019. 2000. View Article : Google Scholar : PubMed/NCBI
|